Zymeworks (FRA:ZA8) Short-Term Capital Lease Obligation : €3.82 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Zymeworks Short-Term Capital Lease Obligation?

Zymeworks's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €3.82 Mil.

Zymeworks's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€3.60 Mil) to Dec. 2023 (€3.91 Mil) but then declined from Dec. 2023 (€3.91 Mil) to Mar. 2024 (€3.82 Mil).

Zymeworks's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€1.16 Mil) to Dec. 2022 (€3.14 Mil) and increased from Dec. 2022 (€3.14 Mil) to Dec. 2023 (€3.91 Mil).

Zymeworks Short-Term Capital Lease Obligation Historical Data

The historical data trend for Zymeworks's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zymeworks Short-Term Capital Lease Obligation Chart

Zymeworks Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.15

2.23

1.16

3.14

3.91

Zymeworks Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															3.15	3.36	3.60	3.91	3.82

Zymeworks Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Zymeworks Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Zymeworks's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Zymeworks (FRA:ZA8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zymeworks Inc (FRA:ZA8) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

ZYME:USA

Address

108 Patriot Drive, Suite A, Middletown, DE, USA, 19709

Website

https://www.zymeworks.com

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Zymeworks (FRA:ZA8) Headlines

No Headlines